New Fortress Energy
NFE
Hutchmed (China)
HCM
Halozyme Therapeutics
HALO
Workday
WDAY
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 33.30%1.61B | 17.57%439.49M | 59.78%633.19M | -16.03%189.79M | 64.15%347.35M | -2.72%1.21B | 78.40%373.8M | -10.67%396.29M | -8.75%226.01M | -37.87%211.61M |
Net income from continuing operations | 20.67%626.03M | -158.86%-2.52M | -0.81%399.27M | 87.54%208.11M | 1,997.92%21.17M | 3.59%518.78M | 121.76%4.28M | 21.74%402.52M | -34.19%110.97M | -95.25%1.01M |
Operating gains losses | -219.28%-22.99M | --0 | --0 | --0 | -3,024.68%-22.99M | -1,026.64%-7.2M | --1K | ---6.96M | ---1.03M | --786K |
Depreciation and amortization | 11.95%956.18M | 12.25%244.6M | 12.05%246.04M | 15.03%239.13M | 8.45%226.41M | 4.44%854.14M | 6.37%217.91M | 5.65%219.57M | 3.17%207.88M | 2.52%208.77M |
Deferred tax | -155.30%-29.18M | -136.90%-5.54M | -164.28%-19.9M | 142.23%19.85M | -1,583.87%-23.59M | 41.40%52.76M | 1,370.13%15.01M | 85.82%30.95M | -49.15%8.19M | -139.85%-1.4M |
Other non cash items | 345.69%136.98M | 38.52%69.85M | 48.56%-54.2M | 137.47%56.16M | 366.40%65.17M | 52.62%-55.75M | 230.41%50.42M | -10.05%-105.36M | 253.04%23.65M | -176.00%-24.46M |
Change In working capital | 53.16%-80.74M | 55.94%126.52M | 137.22%55.65M | -165.74%-338.15M | 223.43%75.25M | -1,171.97%-172.36M | 39.62%81.13M | -622.21%-149.51M | -1.29%-127.25M | -68.84%23.27M |
-Change in receivables | 57.44%-21.71M | 90.67%403.11M | -12.59%-220.19M | -210.88%-290.93M | 223.13%86.29M | 49.60%-51.02M | 10.41%211.42M | -16.04%-195.56M | 51.28%-93.58M | -60.67%26.71M |
-Change in inventory | 81.60%-7.9M | 9,331.91%26.6M | 2,125.55%21.01M | -115.65%-59.87M | 130.39%4.37M | 48.59%-42.91M | 102.60%282K | 97.29%-1.04M | -23.82%-27.76M | -21.02%-14.39M |
-Change in payables and accrued expense | 102.48%1.82M | -109.14%-197.95M | 173.16%65.87M | 209.30%52.08M | 518.89%81.82M | -185.28%-73.23M | 43.86%-94.65M | -82.31%24.11M | -78.46%16.84M | -148.86%-19.53M |
-Change in other current assets | 42.29%-41.27M | 79.69%-15.73M | -74.16%33.1M | 82.59%-8.2M | 32.79%-50.44M | -120.26%-71.51M | -863.03%-77.45M | -15.72%128.1M | -132.91%-47.11M | -214.02%-75.06M |
-Change in other current liabilities | -117.61%-11.68M | -315.57%-89.52M | 248.26%155.86M | -228.14%-31.23M | -144.34%-46.79M | 124.77%66.31M | -23.27%41.53M | -2.88%-105.13M | 118.40%24.37M | 221.11%105.54M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 33.30%1.61B | 17.57%439.49M | 59.78%633.19M | -16.03%189.79M | 64.15%347.35M | -2.72%1.21B | 78.40%373.8M | -10.67%396.29M | -8.75%226.01M | -37.87%211.61M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -14.13%-1.93B | -1.30%-464.31M | -65.34%-582.21M | -7.55%-463.02M | 6.43%-424.09M | -4.71%-1.69B | -15.70%-458.35M | 17.66%-352.13M | -2.53%-430.53M | -21.08%-453.24M |
Capital expenditure reported | -21.82%-2.25B | 0.04%-531.62M | -68.00%-665.85M | -12.88%-533.97M | -16.30%-517.76M | -8.13%-1.85B | -23.50%-531.84M | 8.60%-396.33M | -4.74%-473.02M | -13.68%-445.17M |
Net business purchase and sale | 260.35%84.32M | 238.98%20M | -5.46%16.54M | --9.1M | --38.68M | --23.4M | --5.9M | --17.5M | --0 | --0 |
Net investment purchase and sale | -1,003.72%-23.43M | -197.55%-13.26M | 30.13%-10.19M | --0 | 102.81%16K | 51.20%-2.12M | -6.96%13.6M | 20.50%-14.58M | 0.00%-570K | -936.36%-570K |
Net other investing changes | 94.64%254.68M | 12.18%60.58M | 87.21%77.28M | 43.63%61.85M | 833.09%54.97M | 39.50%130.84M | 171.83%54M | 69.64%41.28M | 33.33%43.06M | -143.35%-7.5M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -14.13%-1.93B | -1.30%-464.31M | -65.34%-582.21M | -7.55%-463.02M | 6.43%-424.09M | -4.71%-1.69B | -15.70%-458.35M | 17.66%-352.13M | -2.53%-430.53M | -21.08%-453.24M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -33.69%322.69M | -127.58%-20.52M | 84.14%-5.82M | 30.39%267.61M | -66.60%81.42M | 31.01%486.68M | -59.66%74.39M | 3.77%-36.7M | 9.48%205.23M | 546.01%243.75M |
Net issuance payments of debt | -55.80%397.18M | -237.49%-255.05M | 55.67%92.05M | 20.60%376.18M | -46.19%184M | 16.05%898.51M | -36.86%185.5M | 6.26%59.13M | 6.89%311.91M | 157.11%341.97M |
Net common stock issuance | 8,441.78%341.43M | 14,196.90%345.23M | 9.30%423K | 162.50%273K | -110.77%-4.5M | -54.28%-4.09M | 9.80%-2.45M | -24.12%387K | -81.33%104K | -112.44%-2.14M |
Cash dividends paid | -2.12%-394.66M | -2.09%-100.07M | -2.15%-98.29M | -2.14%-98.21M | -2.09%-98.08M | -2.01%-386.49M | -2.07%-98.03M | -2.04%-96.22M | -1.99%-96.16M | -1.92%-96.08M |
Net other financing activities | 0.00%-21.26M | 0.00%-10.63M | --0 | ---- | ---- | 0.00%-21.26M | 0.00%-10.63M | ---1K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -33.69%322.69M | -127.58%-20.52M | 84.14%-5.82M | 30.39%267.61M | -66.60%81.42M | 31.01%486.68M | -59.66%74.39M | 3.77%-36.7M | 9.48%205.23M | 546.01%243.75M |
Net cash flow | ||||||||||
Beginning cash position | 2.55%4.96M | 225.46%49.17M | -47.68%4.01M | 38.60%9.63M | 2.55%4.96M | -51.53%4.83M | 114.85%15.11M | -73.76%7.66M | -50.24%6.95M | -51.53%4.83M |
Current changes in cash | -1,008.13%-1.12M | -346.50%-45.33M | 506.23%45.16M | -895.90%-5.63M | 120.81%4.68M | 102.39%123K | -361.50%-10.15M | 133.62%7.45M | -95.36%707K | -47.01%2.12M |
End cash Position | -22.54%3.84M | -22.54%3.84M | 225.46%49.17M | -47.68%4.01M | 38.60%9.63M | 2.55%4.96M | 2.55%4.96M | 114.85%15.11M | -73.76%7.66M | -50.24%6.95M |
Free cash flow | -0.11%-639.37M | 41.70%-92.13M | -67,927.08%-32.65M | -39.34%-344.18M | 27.04%-170.4M | -37.04%-638.67M | 28.52%-158.04M | -100.48%-48K | -21.11%-247.02M | -358.20%-233.57M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |